JAK inhibitors in systemic juvenile idiopathic arthritis
ObjectiveSystemic juvenile idiopathic arthritis (SJIA) is characterized by excessive and inappropriate production of proinflammatory cytokines. Janus kinase inhibitors (JAKi) can block the downstream pathway of many cytokines. The use of JAKi in SJIA or macrophage activation syndrome (MAS) has only...
Guardat en:
| Autors principals: | , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Frontiers Media S.A.
2023-04-01
|
| Col·lecció: | Frontiers in Pediatrics |
| Matèries: | |
| Accés en línia: | https://www.frontiersin.org/articles/10.3389/fped.2023.1134312/full |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|